Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

How Vox analyzed and explained the high prices in emergency departments

When Sarah Kliff, healthcare reporter for Vox, saw an emergency department bill charging more than $600 for an encounter that ended with a band-aid, she and the media company undertook a year-long project to explore as many ED bills as possible.

Thumbnail

CMS Obamacare report reveals drop in unsubsidized enrollment

Enrollment of people who are ineligible for subsidies on the individual healthcare market appears to be slowing down, according to a recent report from CMS.

Thumbnail

Hospital, physician prices jumped over the last 5 years

Hospital prices continue to rise and are a major contributor to overall spending in the healthcare sector, which is expected to hit $6 trillion by 2027.

Thumbnail

Out-of-network billing rises, leaving patients with surprise expenses

Out-of-network billing in emergency departments has risen over the last few years, often leaving patients with surprise expenses even when they have insurance coverage and receive care from an in-network hospital.

Thumbnail

Eli Lilly’s half-price insulin hard to obtain

After drug manufacturer Eli Lilly introduced a half-priced insulin product to the U.S. market, patients are having trouble getting the medication, the Financial Times reported.

Thumbnail

HHS directs $400M to battle opioid abuse epidemic

HHS has awarded $400 million through the Health Resources and Services Administration (HRSA) to fund community health centers, rural organizations and academic institutions to develop and expand services to combat the opioid abuse crisis.

Thumbnail

Pricey cancer treatment will be covered by Medicare

CMS has decided to cover an expensive and new therapy that uses a patient’s own genetically modified immune cells to treat cancer.

Thumbnail

Patients want price transparency in healthcare, but don’t really shop around

Pricing transparency is key for patients having a positive billing experience with their healthcare provider, according to a new survey, but patients aren’t always asking for price estimates or taking the time to shop around for lower-cost services.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup